Bausch Health Companies Inc.
BHC
$7.15
-$0.06-0.83%
| Weiss Ratings | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.49 | |||
| Price History | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.54% | |||
| 30-Day Total Return | -7.38% | |||
| 60-Day Total Return | -15.48% | |||
| 90-Day Total Return | -11.07% | |||
| Year to Date Total Return | -9.95% | |||
| 1-Year Total Return | -22.54% | |||
| 2-Year Total Return | -17.05% | |||
| 3-Year Total Return | -66.90% | |||
| 5-Year Total Return | -60.86% | |||
| 52-Week High % Change | -37.61% | |||
| 52-Week Low % Change | 80.56% | |||
| Price | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.46 | |||
| 52-Week Low Price | $3.96 | |||
| 52-Week Low Price (Date) | Jul 24, 2024 | |||
| 52-Week High Price (Date) | Apr 03, 2024 | |||
| Valuation | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.63B | |||
| Enterprise Value | 24.25B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.13 | |||
| Earnings Per Share Growth | -92.14% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.28 | |||
| Price/Book (Q) | -2.06 | |||
| Enterprise Value/Revenue (TTM) | 2.52 | |||
| Price | $7.15 | |||
| Enterprise Value/EBITDA (TTM) | 7.75 | |||
| Enterprise Value/EBIT | 13.04 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 372.00M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 514 744 6792 | |||
| Address | 2150 St. ElzEar Boulevard West Laval, QC H7L 4A8 | |||
| Website | www.bauschhealth.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 19.32% | |||
| Profit Margin | -0.47% | |||
| Management Effectiveness | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.32% | |||
| Return on Equity | -- | |||
| Income Statement | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 9.52B | |||
| Total Revenue (TTM) | 9.63B | |||
| Revenue Per Share | $25.87 | |||
| Gross Profit (TTM) | 6.84B | |||
| EBITDA (TTM) | 3.13B | |||
| EBIT (TTM) | 1.86B | |||
| Net Income (TTM) | -46.00M | |||
| Net Income Avl. to Common (TTM) | -46.00M | |||
| Total Revenue Growth (Q YOY) | 6.27% | |||
| Earnings Growth (Q YOY) | 308.51% | |||
| EPS Diluted (TTM) | -0.13 | |||
| EPS Diluted Growth (Q YOY) | 327.27% | |||
| Balance Sheet | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.18B | |||
| Cash Per Share (Q) | $3.17 | |||
| Total Current Assets (Q) | 5.77B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -322.00M | |||
| Current Ratio (Q) | 0.855 | |||
| Book Value Per Share (Q) | -$3.48 | |||
| Total Assets (Q) | 26.52B | |||
| Total Current Liabilities (Q) | 6.75B | |||
| Total Debt (Q) | 21.84B | |||
| Total Liabilities (Q) | 26.85B | |||
| Total Common Equity (Q) | -1.28B | |||
| Cash Flow | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -454.00M | |||
| Cash from Financing (TTM) | -868.00M | |||
| Net Change in Cash (TTM) | 239.00M | |||
| Levered Free Cash Flow (TTM) | 1.79B | |||
| Cash from Operations (TTM) | 1.60B | |||
